U.S. Markets closed

Rigel: 3Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $11.5 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 7 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The drug developer posted revenue of $20.9 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $16.3 million.

In the final minutes of trading on Tuesday, the company's shares hit $2.17. A year ago, they were trading at $2.93.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL